Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Stem Cell Transplantation and Immunomodulation in T1DM
NCT02644759Phase 2Completed
- Sponsor
- Stem Cells Arabia
- Start
- Feb 2014
- Primary completion
- Aug 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Autologous CD34+ and CD133+ Stem Cells in type 1 diabetes mellitus (T1D), sponsored by Stem Cells Arabia. Started Feb 2014; status: completed.
02
Drugs
Autologous CD34+ and CD133+ Stem Cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02644759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644759.